ThermoGenesis (THMO) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock THMO vs. HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, VLTO, FTV, and TERShould you be buying ThermoGenesis stock or one of its competitors? The main competitors of ThermoGenesis include HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Veralto (VLTO), Fortive (FTV), and Teradyne (TER). These companies are all part of the "measuring and control equipment" industry. ThermoGenesis vs. Its Competitors HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Veralto Fortive Teradyne HTG Molecular Diagnostics (NASDAQ:HTGMQ) and ThermoGenesis (NASDAQ:THMO) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends. Does the media prefer HTGMQ or THMO? In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score. Company Overall Sentiment HTG Molecular Diagnostics Neutral ThermoGenesis Neutral Which has more volatility & risk, HTGMQ or THMO? HTG Molecular Diagnostics has a beta of 2.67, suggesting that its stock price is 167% more volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Which has better earnings and valuation, HTGMQ or THMO? ThermoGenesis has higher revenue and earnings than HTG Molecular Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/AThermoGenesis$9.61M0.00-$17.98M-$5.14N/A Is HTGMQ or THMO more profitable? Company Net Margins Return on Equity Return on Assets HTG Molecular DiagnosticsN/A N/A N/A ThermoGenesis N/A N/A N/A Do institutionals & insiders hold more shares of HTGMQ or THMO? 5.8% of ThermoGenesis shares are owned by institutional investors. 2.6% of HTG Molecular Diagnostics shares are owned by company insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryThermoGenesis beats HTG Molecular Diagnostics on 4 of the 5 factors compared between the two stocks. Get ThermoGenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THMO vs. The Competition Export to ExcelMetricThermoGenesisLaboratory apparatus & furniture IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$105.01M$5.70B$9.50BDividend YieldN/AN/A4.60%4.01%P/E Ratio0.005.8328.1020.05Price / SalesN/A0.48429.3789.38Price / CashN/A45.3036.2258.56Price / BookN/A2.708.665.87Net Income-$17.98M$18.75M$3.25B$258.55M ThermoGenesis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.06-16.4%N/A-22.6%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.03-1.4%N/A+169.8%$0.00$41.52M0.001Positive NewsGap DownQSIAWQuantum-SiN/A$0.600.0%N/AN/A$0.00$3.44M0.00150Positive NewsSMAPWSportsMap Tech AcquisitionN/A$0.03-8.5%N/A+81.8%$0.00N/A0.00N/AGap DownTTTrane Technologies4.5128 of 5 stars$436.35-0.6%$437.80+0.3%+46.6%$97.31B$19.84B36.3045,000Positive NewsUpcoming EarningsKEYSKeysight Technologies4.0569 of 5 stars$161.85-0.9%$183.00+13.1%+22.5%$27.86B$4.98B37.9915,500VLTOVeralto2.7035 of 5 stars$100.96-1.2%$110.09+9.0%+3.8%$25.02B$5.19B28.8517,000Positive NewsUpcoming EarningsFTVFortive4.9631 of 5 stars$51.13-2.0%$71.85+40.5%-26.4%$17.38B$6.23B22.4218,000Upcoming EarningsAnalyst DowngradeTERTeradyne4.8728 of 5 stars$93.03-2.3%$112.50+20.9%-27.5%$14.92B$2.82B26.286,500News CoverageUpcoming Earnings Related Companies and Tools Related Companies HTGMQ Competitors OLITW Competitors PRENW Competitors QSIAW Competitors SMAPW Competitors TT Competitors KEYS Competitors VLTO Competitors FTV Competitors TER Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:THMO) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ThermoGenesis Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ThermoGenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
